Facebook Instagram Twitter RSS Feed PodBean Back to top on side

Overexpression of AEG-1 in renal cell carcinoma and its correlation with tumor nuclear grade and progression

In: NEOPLASMA, vol. 57, no. 6
W Chen - Z Ke - H Shi - S Yang - L Wang
Detaily:
Rok, strany: 2010, 522 - 529
O článku:
The study was aimed at detecting the expression of a newly found oncogene, astrocyte elevated gene-1 (AEG-1), in renal cell carcinoma (RCC) and its correlation with histopathologic features and the survival of patients. Real-time reverse transcription-PCR and Western blot showed markedly higher expression of AEG-1 in 8 cases of RCC tissue compared with the paired normal tissue from the same patient. The expression level of AEG-1 was also increased in four RCC cell lines in contrast with normal tubular epithelial human kidney cells 2 (HK-2) at both mRNA and protein levels. Furthermore, immunohistochemistry analysis showed highly expressed AEG-1 in 96 of 102 (94.1%) cases of paraffin-embedded archival RCC tissue. Statistical analysis showed a significant correlation of AEG-1 expression with tumor grade (P <0.001), clinical staging (P = 0.003), T classification (P = 0.003) as well as metastasis classification (P=0.032). The means for survival time of low AEG-1 expression group was 76.98m<br />while high AEG-1expression group was 60.94m. Our results suggest that AEG-1 protein is overexpressed in RCC and plays an important role in tumor differentiation and progression. <br />High AEG-1 expression is closely associated with poor prognosis. Keywords: Astrocyte elevated gene-1, AEG-1, renal cell carcinoma, prognosis
Ako citovať:
ISO 690:
Chen, W., Ke, Z., Shi, H., Yang, S., Wang, L. 2010. Overexpression of AEG-1 in renal cell carcinoma and its correlation with tumor nuclear grade and progression. In NEOPLASMA, vol. 57, no.6, pp. 522-529. 0028-2685.

APA:
Chen, W., Ke, Z., Shi, H., Yang, S., Wang, L. (2010). Overexpression of AEG-1 in renal cell carcinoma and its correlation with tumor nuclear grade and progression. NEOPLASMA, 57(6), 522-529. 0028-2685.